| scholarly article | Q13442814 |
| P2093 | author name string | Hao Wang | |
| Ye Ma | |||
| Linlin Jing | |||
| Xuegang Sun | |||
| Yu Dai | |||
| Chunhui Chen | |||
| Yawei Liu | |||
| Qinrui Han | |||
| P2860 | cites work | Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis | Q24311815 |
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis | Q28594624 | ||
| Molecular mechanisms of necroptosis: an ordered cellular explosion | Q29616004 | ||
| Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 | Q29616161 | ||
| Shikonin circumvents cancer drug resistance by induction of a necroptotic death | Q80358241 | ||
| The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis | Q33641040 | ||
| Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs) | Q33841579 | ||
| RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation | Q33869714 | ||
| Regulated necrosis: the expanding network of non-apoptotic cell death pathways. | Q34039639 | ||
| Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. | Q34413744 | ||
| Colorectal cancer statistics, 2017. | Q34552373 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases | Q35709696 | ||
| Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. | Q35921769 | ||
| Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death | Q36347249 | ||
| Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis | Q36866492 | ||
| RIP kinases at the crossroads of cell death and survival | Q37562142 | ||
| A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | Q37644337 | ||
| The role of the kinases RIP1 and RIP3 in TNF-induced necrosis | Q37721675 | ||
| Killing a cancer: what are the alternatives? | Q38009194 | ||
| IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis | Q38775054 | ||
| An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death. | Q38858686 | ||
| Treatments for colorectal liver metastases: A new focus on a familiar concept. | Q39033363 | ||
| Necroptosis and Cancer. | Q39268644 | ||
| Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells | Q39878879 | ||
| Targeting the weak point of cancer by induction of necroptosis | Q40109919 | ||
| Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes. | Q42939569 | ||
| RIP kinases initiate programmed necrosis | Q43292317 | ||
| NF-kappaB inhibitor sesquiterpene parthenolide induces concurrently atypical apoptosis and cell necrosis: difficulties in identification of dead cells in such cultures | Q44524735 | ||
| Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity | Q46634405 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| necroptosis | Q3346925 | ||
| Bufogenin | Q27114274 | ||
| P304 | page(s) | 201 | |
| P577 | publication date | 2018-07-20 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis | |
| P478 | volume | 16 |
| Q98177427 | Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses |
| Q91260101 | Current translational potential and underlying molecular mechanisms of necroptosis |
| Q59811858 | Necroptosis in inflammatory bowel disease and other intestinal diseases |
| Q89477059 | Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer |
| Q64279044 | The role of necroptosis in cancer biology and therapy |
Search more.